114 related articles for article (PubMed ID: 27643871)
21. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers.
Bazarbachi A; Labopin M; Ghavamzadeh A; Giebel S; Al-Zahrani H; Ladeb S; Leone G; Abdel-Rahman F; Liso V; Hamidieh AA; Rasheed W; Ibrahim A; Alabdulaaly A; Kyrcz-Krzemien S; Arnold R; Kharfan-Dabaja MA; Alimoghaddam K; Aljurf M; Mohty M
Bone Marrow Transplant; 2013 Aug; 48(8):1065-9. PubMed ID: 23353802
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation for thalassemia.
Elborai Y; Uwumugambi A; Lehmann L
Immunotherapy; 2012 Sep; 4(9):947-56. PubMed ID: 23046238
[TBL] [Abstract][Full Text] [Related]
23. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation.
Caocci G; Efficace F; Ciotti F; Roncarolo MG; Vacca A; Piras E; Littera R; Dawood Markous RS; Collins GS; Ciceri F; Mandelli F; Marktel S; La Nasa G
Biol Blood Marrow Transplant; 2011 Jun; 17(6):861-6. PubMed ID: 20870029
[TBL] [Abstract][Full Text] [Related]
24. A comparison of allografting with autografting for newly diagnosed myeloma.
Bruno B; Rotta M; Patriarca F; Mordini N; Allione B; Carnevale-Schianca F; Giaccone L; Sorasio R; Omedè P; Baldi I; Bringhen S; Massaia M; Aglietta M; Levis A; Gallamini A; Fanin R; Palumbo A; Storb R; Ciccone G; Boccadoro M
N Engl J Med; 2007 Mar; 356(11):1110-20. PubMed ID: 17360989
[TBL] [Abstract][Full Text] [Related]
25. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
26. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
[TBL] [Abstract][Full Text] [Related]
27. Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation.
Pérez-García A; De la Cámara R; Torres A; González M; Jiménez A; Gallardo D
Haematologica; 2005 Dec; 90(12):1723-4. PubMed ID: 16330460
[TBL] [Abstract][Full Text] [Related]
28. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia.
La Nasa G; Caocci G; Efficace F; Dessì C; Vacca A; Piras E; Sanna M; Marcias M; Littera R; Carcassi C; Lucarelli G
Blood; 2013 Sep; 122(13):2262-70. PubMed ID: 23958950
[TBL] [Abstract][Full Text] [Related]
29. KIR2DS4 and Its Variant KIR1D Are Associated with Acute Graft-versus-Host Disease, Cytomegalovirus, and Overall Survival after Sibling-Related HLA-Matched Transplantation in Patients with Donors with KIR Gene Haplotype A.
Wu X; Yao Y; Bao X; Zhou H; Tang X; Han Y; Ma X; Liu Y; Chen J; Zhou H; Jing S; Gu B; Xu Y; Sun A; He J; Wu D
Biol Blood Marrow Transplant; 2016 Feb; 22(2):220-225. PubMed ID: 26476204
[TBL] [Abstract][Full Text] [Related]
30. Progress in hematopoietic stem cell transplantation as allogeneic cellular gene therapy in thalassemia.
Isgrò A; Gaziev J; Sodani P; Lucarelli G
Ann N Y Acad Sci; 2010 Aug; 1202():149-54. PubMed ID: 20712786
[TBL] [Abstract][Full Text] [Related]
31. [Allogeneic hematopoietic stem cell transplantation for beta-thalassemia major].
Li CF; He YL; Zhang YM; Yang M; Wu XD; Bai J
Zhonghua Xue Ye Xue Za Zhi; 2003 Apr; 24(4):174-6. PubMed ID: 12864945
[TBL] [Abstract][Full Text] [Related]
32. Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.
Nakane T; Nakamae H; Yamaguchi T; Kurosawa S; Okamura A; Hidaka M; Fuji S; Kohno A; Saito T; Aoyama Y; Hatanaka K; Katayama Y; Yakushijin K; Matsui T; Yamamori M; Takami A; Hino M; Fukuda T
Int J Hematol; 2017 Apr; 105(4):485-496. PubMed ID: 27943166
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic transplantation for bone marrow failure syndromes and thalassemia.
Sevilla J; Fernández-Plaza S; Diaz MA; Madero L;
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S17-21. PubMed ID: 15812523
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic stem cell transplantation for Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
Vlachos A; Federman N; Reyes-Haley C; Abramson J; Lipton JM
Bone Marrow Transplant; 2001 Feb; 27(4):381-6. PubMed ID: 11313667
[TBL] [Abstract][Full Text] [Related]
35. Through the eyes of young sibling donors: the hematopoietic stem cell donation experience.
D'Auria JP; Fitzgerald TM; Presler CM; Kasow KA
J Pediatr Nurs; 2015; 30(3):447-53. PubMed ID: 25579158
[TBL] [Abstract][Full Text] [Related]
36. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.
Bashey A; Zhang X; Sizemore CA; Manion K; Brown S; Holland HK; Morris LE; Solomon SR
J Clin Oncol; 2013 Apr; 31(10):1310-6. PubMed ID: 23423745
[TBL] [Abstract][Full Text] [Related]
37. Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors.
Ludajic K; Rosenmayr A; Faé I; Fischer GF; Balavarca Y; Bickeböller H; Kalhs P; Greinix HT
Transplantation; 2009 Nov; 88(10):1227-8. PubMed ID: 19935378
[No Abstract] [Full Text] [Related]
38. [Clinical contrasting study on hematopoietic stem cell transplantation from HLA-identical sibling and partially HLA-mismatched related donors].
Wang LH; Ren HY; Li Y; Qiu ZX; Cen XN; Ou JP; Xu WL; Wang MJ; Wang Y; Dong YJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Aug; 29(8):507-11. PubMed ID: 19112911
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
40. Alpha/beta T-cell depleted grafts as an immunological booster to treat graft failure after hematopoietic stem cell transplantation with HLA-matched related and unrelated donors.
Rådestad E; Wikell H; Engström M; Watz E; Sundberg B; Thunberg S; Uzunel M; Mattsson J; Uhlin M
J Immunol Res; 2014; 2014():578741. PubMed ID: 25371909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
